Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2005
12/29/2005US20050287517 Modulator of sweet or umami taste using ligand binding assay; detecting change in conformation
12/29/2005US20050287168 Recombinant spores
12/29/2005US20050287166 Malarial pre-erythrocytic stage polypeptide molecules
12/29/2005US20050287164 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/29/2005US20050287163 Mycoplasma polypeptides
12/29/2005US20050287159 Treatment methods for eotaxin mediated inflammatory conditons
12/29/2005US20050287151 Secreted protein therapeutics and uses thereof
12/29/2005US20050287148 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
12/29/2005US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis
12/29/2005US20050287141 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2005US20050287118 Bacterial plasmid with immunological adjuvant function and uses thereof
12/29/2005US20050287098 Compositions and methods for controlling hair growth
12/29/2005CA2570508A1 Preparation of protective antigen from bacillus anthracis
12/29/2005CA2570171A1 Methods of making nanotechnological and macromolecular biomimetic structures
12/29/2005CA2570034A1 Diagnosis and treatment of siglec-6 associated diseases
12/28/2005EP1610127A1 N1,n12-diacetylspermine as tumor marker
12/28/2005EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP)
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609858A1 Branched neutral amino acid transporters acting as single molecule
12/28/2005EP1609856A2 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
12/28/2005EP1609853A1 Process for controlling sialylation of proteins produced by mammalian cell culture
12/28/2005EP1608967A2 Compositions and methods for the diagnosis and treatment of tumor
12/28/2005EP1608767A2 Optimized expression of hpv 31 l1 in yeast
12/28/2005EP1608748A2 Ligational encoding of small molecules
12/28/2005EP1608736A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof
12/28/2005EP1608320A2 Novel imidazoline receptor homologs
12/28/2005EP1608312A2 Methods for obtaining colonization factors from bacterial strains
12/28/2005EP1565570A4 Diagnosis of sepsis or sirs using biomarker profiles
12/28/2005EP1507852A4 Nucleic acids and proteins with thioredoxin reductase activity
12/28/2005EP1364029B1 FUSION PROTEIN comprising hirudin and proinsulin or insulin
12/28/2005EP1335987B1 Modified vaccinia ankara virus variant
12/28/2005EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides
12/28/2005EP1123114B1 Virus-like particles for the induction of autoantibodies
12/28/2005EP1092037B1 Cell culture process for producing glycoproteins
12/28/2005EP1073683B1 G-csf receptor agonist antibodies and screening method therefor
12/28/2005EP1025227B1 Human toll homologues
12/28/2005EP0971959B1 Humanized antibodies and methods for forming humanized antibodies
12/28/2005EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/28/2005EP0920448B1 Truncated glial cell line-derived neurotrophic factor
12/28/2005EP0859840B1 Biologically active eph family ligands
12/28/2005EP0682529B2 Antibody for the treatment of insulin dependent diabetes
12/28/2005EP0662134B1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof
12/28/2005EP0652964B1 K. lactis transaldolase gene promoter and use thereof
12/28/2005EP0646175B1 Recombinant pseudomonas exotoxin with increased activity
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1714148A Viral deconstruction through capsid assembly in vitro
12/28/2005CN1714147A Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
12/28/2005CN1233841C Process for preparing bioactive peptide-silk fibroin peptide
12/28/2005CN1233840C Preparation process and product of collagenic polypeptide
12/28/2005CN1233839C Productive method of recombinant human liver regenerated enhanced factor
12/28/2005CN1233830C China bee and hornet hemolysis peptide precursor gene and coded polypeptide and preparing method
12/28/2005CN1233820C Bacterial host strains
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/27/2005US6979733 Comprises nucleotide sequences coding biocatalyst polypeptide for hydrolysis of epoxides and arene oxides into diols such as glycidol and atenolol; antiinflammatory/hypotensive agents
12/27/2005US6979726 Immunoconjugates
12/27/2005US6979557 Comprise olignucleotide sequences associated with translation initiation for analyzing the function of polypeptide
12/27/2005US6979555 Hyaluronan receptor for endocytosis
12/27/2005US6979546 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/27/2005CA2158018C Improved feedcrops enriched in sulfur amino acids and methods for improvement
12/27/2005CA2137280C Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
12/22/2005WO2005121351A2 Methods for transforming and expression screening of filamentous fungal cells with a dna library
12/22/2005WO2005121342A1 Recombinant enterotoxin c and vaccine with the use of the same
12/22/2005WO2005121339A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005WO2005121338A1 Anti-perp antibody
12/22/2005WO2005120700A2 Peptide purification by means of hard metal ion affinity chromatography
12/22/2005WO2005104763A3 Improved method for identifying peptides in a biological sample
12/22/2005WO2005096706A3 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
12/22/2005WO2005094446A3 Anti-myostatin antibodies
12/22/2005WO2005051289A3 Homogeneous preparations of chimeric proteins
12/22/2005WO2005045013A3 Recombinant microorganism
12/22/2005WO2005013912A3 Anti-fcrn antibodies for treatment of auto/allo immune conditions
12/22/2005WO2004111074A3 In vivo production of a clostridial neurotoxin light chain peptide
12/22/2005WO2004094613A3 Polyvalent protein complex
12/22/2005WO2004085623A3 A compact synthetic expression vector comprising double-stranded dna molecules and methods of use thereof
12/22/2005WO2004072241A3 Compositions and methods for cleaving iap
12/22/2005WO2004070004A3 Rat receptor tyrosine kinase, kdr
12/22/2005WO2003080796A3 Ordered biological nanostructures formed from chaperonin polypeptides
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283848 Expression of eukaryotic peptides in plant plastids
12/22/2005US20050283617 Motor vehicle documents
12/22/2005US20050283000 Process for the production of a heterologous protein
12/22/2005US20050282752 IL-1ra variants
12/22/2005US20050282736 ligating recombinant intein domains to a linear synthetic protein to form a compound D1-X(n)-D2, where D1 and D2 are catalytic domains of an intein and X is a protein; cell-free; producing small cyclic peptides containing non-genetically encodable amino acids; for drugs
12/22/2005US20050282256 Adipocyte complement related protein zacrp13
12/22/2005US20050282254 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proteins
12/22/2005US20050282250 Method for the recombinant production and purification of protein kinases
12/22/2005US20050282249 Recombinant hexose oxidase, a method of producing same and use of such enzyme
12/22/2005US20050282247 Recombinant single chain antibody in heterotrophic algae for pathogen control and use
12/22/2005US20050282240 Method for identifying peptides in a biological sample
12/22/2005US20050282230 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282222 Nematode PAN and ZP receptor-like sequences
12/22/2005US20050282217 Using TR10 polypeptide, which is a member of the tumor necrosis factor (TNF) receptor superfamily for inhibiting apoptosis associated with HIV infection
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282179 Biomarkers for interferon-alpha response in hepatitis C virus infected patients
12/22/2005US20050282169 Signatory sequences
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 1125